CONTERA PHARMA A/S — Credit Rating and Financial Key Figures
CVR number: 33062214
Venlighedsvej 4, 2970 Hørsholm
ts@conterapharma.com
tel: 31186611
www.conterapharma.com
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | -9 724.55 | -24 154.46 | -45 152.32 | -58 993.91 | -54 083.95 |
| Employee benefit expenses | -3 720.09 | -12 111.66 | -12 905.55 | -17 993.65 | -19 858.78 |
| Other operating expenses | -41.99 | ||||
| Total depreciation | -51.72 | - 126.06 | -4 025.81 | -1 272.11 | -1 641.65 |
| EBIT | -13 496.37 | -36 392.18 | -62 083.69 | -78 259.67 | -75 626.37 |
| Other financial income | 0.52 | 36.42 | 328.74 | 2 028.67 | 1 339.98 |
| Other financial expenses | - 339.19 | - 225.07 | - 613.38 | - 589.30 | - 427.35 |
| Pre-tax profit | -13 835.04 | -36 580.83 | -62 368.33 | -76 820.30 | -74 713.74 |
| Income taxes | 1 576.06 | 5 061.99 | 5 500.00 | 5 500.00 | 5 500.00 |
| Net earnings | -12 258.98 | -31 518.83 | -56 868.33 | -71 320.30 | -69 213.74 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Machinery and equipment | 321.18 | 364.39 | 5 302.06 | 7 881.57 | 7 195.60 |
| Tangible assets total | 321.18 | 364.39 | 5 302.06 | 7 881.57 | 7 195.60 |
| Investments total | 280.13 | 441.92 | 918.90 | 664.43 | 586.45 |
| Long term receivables total | |||||
| Inventories total | |||||
| Current amounts owed by group member comp. | 2 256.88 | 1 428.77 | |||
| Prepayments and accrued income | 1 865.94 | 415.76 | 12 211.58 | 7 717.82 | 3 665.05 |
| Current other receivables | 969.75 | 920.24 | 3 272.72 | 1 146.18 | 3 738.72 |
| Current deferred tax assets | 1 670.06 | 5 183.73 | 5 524.44 | 5 573.98 | 5 521.19 |
| Short term receivables total | 4 505.76 | 6 519.73 | 21 008.74 | 16 694.87 | 14 353.72 |
| Cash and bank deposits | 196 218.79 | 159 886.57 | 88 513.13 | 67 127.71 | 41 474.01 |
| Cash and cash equivalents | 196 218.79 | 159 886.57 | 88 513.13 | 67 127.71 | 41 474.01 |
| Balance sheet total (assets) | 201 325.86 | 167 212.61 | 115 742.83 | 92 368.58 | 63 609.78 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 621.44 | 621.44 | 621.44 | 652.69 | 1 403.19 |
| Retained earnings | 206 598.44 | 194 339.47 | 162 820.64 | 156 965.65 | 122 198.75 |
| Profit of the financial year | -12 258.98 | -31 518.83 | -56 868.33 | -71 320.30 | -69 213.74 |
| Shareholders equity total | 194 960.91 | 163 442.08 | 106 573.75 | 86 298.04 | 54 388.19 |
| Non-current liabilities total | |||||
| Current trade creditors | 5 343.05 | 1 897.70 | 8 373.80 | 3 355.57 | 7 755.28 |
| Short-term deferred tax liabilities | 69.73 | ||||
| Other non-interest bearing current liabilities | 1 021.90 | 1 803.09 | 795.28 | 2 714.96 | 1 466.31 |
| Current liabilities total | 6 364.94 | 3 770.52 | 9 169.08 | 6 070.53 | 9 221.59 |
| Balance sheet total (liabilities) | 201 325.86 | 167 212.61 | 115 742.83 | 92 368.58 | 63 609.78 |
CreditReports API
- Company information
- Financial data
- Credit risk data
- All 400,000+ Danish companies
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.